Top compounds associated with response to ADGRE2


Feature Type Standardized
Nominal ANOVA
mRNA linifanib GDSC1000 pan-cancer AAC 0.36 9e-23
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.29 1e-16
mRNA AC220 GDSC1000 pan-cancer AAC 0.29 1e-15
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.36 8e-12
mRNA XL-184 GDSC1000 pan-cancer AAC 0.23 7e-11
mRNA TAE684 CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.33 2e-09
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.2 5e-09
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC 0.2 5e-09
mRNA PD-0325901 gCSI pan-cancer AAC 0.29 8e-09
Download CSV